SCHEMBL18800867

SCHEMBL18800867

CC(C)Oc1ccc(-c2cncc(N)c2C(=N)N)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ BTK Q06187 1/20 0.50
▸ MAP4K4 O95819 3/20 0.42
▸ FDPS P14324 2/20 0.40
▸ CYP1A2 P05177 1/20 0.40
▸ GAA P10253 1/20 0.40
▸ CYP2D6 P10635 1/20 0.40
▸ CYP2C19 P33261 1/20 0.40
▸ PARP10 Q53GL7 1/20 0.39
▸ GLA P06280 1/20 0.36
▸ PIK3CD O00329 1/20 0.35
▸ PIP5K1C O60331 1/20 0.35
▸ PIK3CA P42336 1/20 0.35
▸ PIK3CB P42338 1/20 0.35
▸ PI4KA P42356 1/20 0.35
▸ PIK3CG P48736 1/20 0.35
▸ PI4KB Q9UBF8 1/20 0.35
▸ PRKAB2 O43741 1/20 0.35
▸ PRKAG1 P54619 1/20 0.35
▸ PRKAA2 P54646 1/20 0.35
▸ PRKAA1 Q13131 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18800557 0.85 PRSS1 (0.45) MAP4K4CYP1A2CYP2D6CYP2C19MAPT
SCHEMBL18800606 0.81 NQO2 (0.43) BTKMAP4K4CYP1A2CYP2D6CYP2C19
SCHEMBL18800739 0.80 MEN1 (0.39) BTKPARP10KMT2AF10PRSS1
SCHEMBL18800873 0.78 SCN5A (0.37) PRMT6
SCHEMBL18800479 0.75 BTK (0.54) BTKMAP4K4FDPSPARP10
SCHEMBL18800626 0.75 SMN1; SMN2 (0.48) BTKCYP1A2GAACYP2D6CYP2C19
SCHEMBL18800610 0.73 BTK (0.43) BTKMAP4K4GAAMAPTKMT2A
SCHEMBL18800598 0.72 KDM4E (0.51) CYP1A2CYP2D6CYP2C19MAPTPRSS1
SCHEMBL18800738 0.72 TDO2 (0.49) CYP1A2CYP2D6CYP2C19GLAMAPT
SCHEMBL30047284 0.70 MAP4K4 (0.57) BTKMAP4K4CYP1A2GAACYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2789615-B1 Azaindazoles as Btk kinase modulators and use thereof BRISTOL MYERS SQUIBB CO (US) 2017-05-03 — — EP disclosed
Send feedback